Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1 2Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia 4Lymphoma, Non-Hodgkin 2Lymphoma 2Thalassemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Leukemia, Prolymphocytic 1Kidney Transplantation 1Kidney Neoplasms 1Hodgkin Disease 1Hematologic Neoplasms 1Hematologic Diseases 1Carcinoma, Renal Cell 1

Interventions

spartalizumab 1liposomal doxorubicin 1Salvia hispanica seed extract 1Rituximab 1Prednisone 1Methotrexate 1Gemcitabine 1Dexamethasone 1Clinical Protocols 1Cisplatin 1Cholecalciferol 1Azacitidine 1Asparaginase 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, T-Cell × Alemtuzumab × Clear all
NCT00038883 2018-11-07

Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies

M.D. Anderson Cancer Center

Phase NA Terminated
19 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡